Is This Growth Stock Undervalued?
24/9 15:45
Biotech company Bluebird Bio (NASDAQ: BLUE) is currently riding high. Over the past month, the gene-editing specialist has earned approval for not one but two innovative treatments in the U.S. That is a feat very few gene-editing experts have achieved. Despite these accomplishmen...